<?xml version="1.0" encoding="UTF-8"?>
<p class="p">NF-κB is an important factor in the regulation of immune responses in allergic diseases, and has been considered a prototypical pro-inflammatory signaling pathway (
 <xref rid="B21" ref-type="bibr" class="xref">Kim et al., 2017</xref>). The effect of 
 <italic class="italic">ZCO</italic> on NF-κB activation was tested in 293T cells. PMA increased NF-κB transcription, which was decreased by 
 <italic class="italic">ZCO</italic> in a dose-dependent manner, with an IC
 <sub class="sub">50</sub> value of 0.0065%. 
 <italic class="italic">ZCO</italic> at the concentration of 0.01% showed the most significant reduction on the activation of NF-κB transcription (Figure 
 <xref ref-type="fig" rid="F6" class="xref">6A</xref>).
</p>
